Timothy He

2.0k citations
9 papers · 868 indexed · h-index 9

Impact in

    • Cancer, Hypoxia, and Metabolism
    • Epigenetics and DNA Methylation
    • RNA modifications and cancer
    • Cancer-related gene regulation
    • Genomics and Chromatin Dynamics

Papers in

Timothy He

9 papers receiving 849 citations

Peers

Timothy He
Comparison fields: 5 of 86
  • Cancer Research 172
  • Molecular Biology 641
  • Pharmaceutical Science 45
  • Oncology 131
  • Rheumatology 68
Replace Bo Jiao with:
Bo Jiao China
Stefan Jaroch Germany
Emile G. Plise United States
Paresh Thakker United States
Yukio Yasukochi Japan
Scilla Latini Denmark
Rogier W. Rooswinkel Netherlands
Chris Feierabend United States
Mercedes Vázquez–Chantada United Kingdom
Matthew A. Leff United States
Timothy He relative to Bo Jiao China Bo Jiao's profile →
Citations per field
00.5×6.2×
Bo Jiao · 1×
Citations per year

Countries citing papers authored by Timothy He

Since Specialization
Citations

This map shows the geographic impact of Timothy He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy He more than expected).

Fields of papers citing papers by Timothy He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy He. The network helps show where Timothy He may publish in the future.

Co-authors

The 25 scholars most cited alongside Timothy He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timothy He Line = papers co-authored together Timothy He links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 2007261
2 2007217
3 2017119
4 2010107
5 200874
6 201138
7 200826
8 201813
9 202013

About Timothy He

Timothy He is a scholar working on Physiology, Pharmaceutical Science, Pharmacology, Molecular Biology and Oncology, having authored 9 papers that have together received 868 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), RNA modifications and cancer (3 papers), Adenosine and Purinergic Signaling (2 papers), Cancer-related gene regulation (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Pharmacological Effects and Toxicity Studies (1 paper), Nanoplatforms for cancer theranostics (1 paper) and Drug Solubulity and Delivery Systems (1 paper). The work is most often cited by research in Cancer Research (172 citations), Molecular Biology (641 citations), Pharmaceutical Science (45 citations), Oncology (131 citations) and Rheumatology (68 citations). Timothy He has collaborated with scholars based in United States, France and Japan. Frequent co-authors include Bailin Zhang, Taiping Chen, Frédérique Gay, En Li, Yoshihide Ueda, Naomi Tsujimoto, Sarah Hevi, Eva Morán, Heinz Linhart and Eveline J. Steine. Their work appears in journals such as SLAS DISCOVERY, Genes & Development, Journal of Pharmaceutical Sciences, Nature Genetics and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026